Detection of SARS-COV-2 Proteins Using an ELISA Test
The coronavirus disease 2019 (COVID-19) global pandemic created an unprecedented public health emergency. Early recognition of an infected person and disruption of the transmission pathway are the keys to controlling this major public health threat around the world. The scientifically reliable scree...
Main Authors: | Marina Di Domenico, Alfredo De Rosa, Mariarosaria Boccellino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/4/698 |
Similar Items
-
Clinical and Analytical Performance of ELISA Salivary Serologic Assay to Detect SARS-CoV-2 IgG in Children and Adults
by: Andrea Padoan, et al.
Published: (2024-01-01) -
The use of nanobodies in a sensitive ELISA test for SARS-CoV-2 Spike 1 protein
by: Georgina C. Girt, et al.
Published: (2021-09-01) -
A Quantitative ELISA Protocol for Detection of Specific Human IgG against the SARS-CoV-2 Spike Protein
by: Rémi Vernet, et al.
Published: (2021-07-01) -
Development and Optimization of In-house ELISA for Detection of Human IgG Antibody to SARS-CoV-2 Full Length Spike Protein
by: Thamir A. Alandijany, et al.
Published: (2020-09-01) -
Development of in House ELISAs to Detect Antibodies to SARS-CoV-2 in Infected and Vaccinated Humans by Using Recombinant S, S1 and RBD Proteins
by: Aysun Yilmaz, et al.
Published: (2022-12-01)